Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Bio Essence (BIOE) over the last 6 years, with Q3 2025 value amounting to 10.42%.

  • Bio Essence's EBIT Margin rose 1191500.0% to 10.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 22.23%, marking a year-over-year increase of 5041100.0%. This contributed to the annual value of 141.83% for FY2024, which is 791700.0% down from last year.
  • As of Q3 2025, Bio Essence's EBIT Margin stood at 10.42%, which was up 1191500.0% from 23.63% recorded in Q2 2025.
  • In the past 5 years, Bio Essence's EBIT Margin registered a high of 95.31% during Q4 2023, and its lowest value of 924.3% during Q1 2025.
  • Moreover, its 5-year median value for EBIT Margin was 73.9% (2022), whereas its average is 111.83%.
  • Examining YoY changes over the last 5 years, Bio Essence's EBIT Margin showed a top increase of 4193900bps in 2025 and a maximum decrease of -8256200bps in 2025.
  • Over the past 5 years, Bio Essence's EBIT Margin (Quarter) stood at 93.3% in 2021, then skyrocketed by 59bps to 38.64% in 2022, then skyrocketed by 347bps to 95.31% in 2023, then tumbled by -97bps to 2.61% in 2024, then skyrocketed by 299bps to 10.42% in 2025.
  • Its EBIT Margin stands at 10.42% for Q3 2025, versus 23.63% for Q2 2025 and 924.3% for Q1 2025.